Below are the financial statements of Mankind Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
All figures in billions of INR | 2024 | 2023 |
---|---|---|
Non-current assets | — | — |
Property, plant and equipment | 28.13a | 24.09a |
Capital work-in-progress | 2.07a | 4.93a |
Investment properties | 0.05a | 0.05a |
Goodwill | 0.2a | 0.2a |
Other intangible assets | 15.88a | 17.01a |
Intangible assets under development | 0.75a | 0.57a |
Right-of-use assets | 1.19a | 1.14a |
Investment in associates and joint ventures | 1.89a | 1.81a |
Financial assets | — | — |
Investments | 1.21a | 0.9a |
Other financial assets | 0.29a | 1.1a |
Income tax assets (net) | 0.82a | 1.03a |
Deferred tax assets (net) | 0.8a | 0.3a |
Other non-current assets | 0.66a | 0.73a |
Total non-current assets | 53.95a | 53.88a |
Current assets | — | — |
Inventories | 15.53a | 14.98a |
Financial assets | — | — |
Investments | 22.58a | 10.75a |
Trade receivables | 8.48a | 5.76a |
Cash and cash equivalents | 3.82a | 3.05a |
Bank balances other than (iii) above | 8.16a | 1.48a |
Loans | 0.03a | 0.02a |
Other financial assets | 0.13a | 0.56a |
Other current assets | 6.92a | 6.63a |
Assets classified as held for sale | 0.03a | 0.03a |
Total current assets | 65.68a | 43.28a |
Total assets | 119.63a | 97.15a |
Equity | — | — |
Equity share capital | 0.4a | 0.4a |
Other equity | 93.23a | 73.95a |
Equity attributable to equity holders of the parent | 93.63a | 74.35a |
Non controlling interest | 2.13a | 1.88a |
Total equity | 95.76a | 76.23a |
Financial liabilities | — | — |
Borrowings | 0.25a | 0.23a |
Lease liabilities | 0.08a | 0.05a |
Non-current liabilities | — | — |
Provisions | 1.23a | 0.98a |
Deferred tax liabilities (net) | 0.89a | 0.77a |
Other non-current liabilities | 0.23a | 0.25a |
Total non-current liabilities | 2.68a | 2.29a |
Financial liabilities | — | — |
Borrowings | 1.71a | 1.39a |
Lease liabilities | 0.03a | 0.03a |
Trade payables | — | — |
Total outstanding dues of micro and small enterprises | 0.79a | 0.61a |
Total outstanding dues of creditors other than micro and small enterprises | 10.24a | 9.48a |
Other financial liabilities | 2.36a | 2.36a |
Current liabilities | — | — |
Provisions | 3.89a | 3.08a |
Current tax liabilities (net) | 0.46a | 0.46a |
Other current liabilities | 1.71a | 1.23a |
Total current liabilities | 21.2a | 18.63a |
Total liabilities | 23.87a | 20.92a |
Total equity and liabilities | 119.63a | 97.15a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Mankind Pharma’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.